Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by ualcin1on Feb 28, 2020 3:31pm
68 Views
Post# 30748799

RE:RE:RE:RE:RE:RE:RE:At 2.48pm today - a big head fake.

RE:RE:RE:RE:RE:RE:RE:At 2.48pm today - a big head fake.stockbuphoon: I keep them. Last year, I took advantage of the warrants that were offered to us, to the point that I was able to neutralize (almost) the dilution that the financial rearrangement of TV had caused. I therefore find myself with an average acquisition cost of $50, which represents, in pre-arrangement dollars, about $1. Prometic has long hovered around this $1 value, after, I must point out, Pierre Laurin's exaggerations were brought to light. That Liminal's stock goes back up to this $1 value (thus to $50 in current dollars) does not seem out of reach to me. Let's remember that in Pierre Laurin's triumphant era (the famous "over-pregnancy"), this stock had reached more than $3, or $150 in post-arrangement dollars. Am I too optimistic? Maybe. But my intuition leads me to remain confident. In any case, I don't have much choice: if I sold now, my losses would be much too high. So I try to be patient...
<< Previous
Bullboard Posts
Next >>